Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3)

ClinicalTrials.gov ID: NCT06272487

Public ClinicalTrials.gov record NCT06272487. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 7:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Zilebesiran Used as Add-on Therapy in Adult Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications

Study identification

NCT ID
NCT06272487
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Alnylam Pharmaceuticals
Industry
Enrollment
375 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Zilebesiran Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2024
Primary completion
Jun 18, 2025
Completion
Nov 30, 2025
Last update posted
Mar 1, 2026

2024 – 2025

United States locations

U.S. sites
139
U.S. states
38
U.S. cities
118
Facility City State ZIP Site status
Clinical Trial Site Alexander City Alabama 35010
Clinical Trial Site Daphne Alabama 36526
Clinical Trial Site Foley Alabama 36535
Clinical Trial Site Huntsville Alabama 35801
Clinical Trial Site Huntsville Alabama 35805
Clinical Trial Site Montgomery Alabama 36117
Clinical Trial Site Gilbert Arizona 85297
Clinical Trial Site Phoenix Arizona 85028
Clinical Trial Site Sun City Arizona 85351
Clinical Trial Site Tempe Arizona 85281
Clinical Trial Site Tucson Arizona 85741
Clinical Trial Site Beverly Hills California 90211
Clinical Trial Site Covina California 91723
Clinical Trial Site Encinitas California 92024
Clinical Trial Site Garden Grove California 92844
Clinical Trial Site Huntington Beach California 92647
Clinical Trial Site Los Angeles California 90022
Clinical Trial Site Los Angeles California 90057
Clinical Trial Site Northridge California 91324
Clinical Trial Site Northridge California 91325
Clinical Trial Site Pasadena California 91105
Clinical Trial Site San Diego California 92108
Clinical Trial Site San Diego California 92111
Clinical Trial Site San Dimas California 91773
Clinical Trial Site Simi Valley California 93065
Clinical Trial Site Vacaville California 95687
Clinical Trial Site Van Nuys California 91405
Clinical Trial Site West Hills California 91307
Clinical Trial Site Colorado Springs Colorado 80918
Clinical Trial Site Denver Colorado 80210
Clinical Trial Site Denver Colorado 80230
Clinical Trial Site Hartford Connecticut 06112
Clinical Trial Site Middlebury Connecticut 06762
Clinical Trial Site Waterbury Connecticut 06708
Clinical Trial Site Washington D.C. District of Columbia 20009
Clinical Trial Site Clearwater Florida 33756
Clinical Trial Site Coral Gables Florida 33134
Clinical Trial Site Daytona Beach Florida 32117
Clinical Trial Site Fort Myers Florida 33912
Clinical Trial Site Hollywood Florida 33021
Clinical Trial Site Jacksonville Florida 32204
Clinical Trial Site Jacksonville Florida 32209
Clinical Trial Site Jacksonville Florida 32256
Clinical Trial Site Jensen Beach Florida 34957
Clinical Trial Site Lake City Florida 32055
Clinical Trial Site Miami Florida 33126
Clinical Trial Site Miami Florida 33135
Clinical Trial Site Miami Florida 33137
Clinical Trial Site Miami Florida 33144
Clinical Trial Site Miami Florida 33155
Clinical Trial Site Miami Florida 33176
Clinical Trial Site Miramar Florida 33027
Clinical Trial Site Orlando Florida 32801
Clinical Trial Site The Villages Florida 32162
Clinical Trial Site Winter Haven Florida 33880
Clinical Trial Site Acworth Georgia 30101
Clinical Trial Site Atlanta Georgia 30322
Clinical Trial Site Columbus Georgia 31904
Clinical Trial Site Douglasville Georgia 30134
Clinical Trial Site Gainesville Georgia 30501
Clinical Trial Site Savannah Georgia 31406
Clinical Trial Site Thomasville Georgia 31792
Clinical Trial Site Boise Idaho 83706
Clinical Trial Site Chicago Illinois 60602
Clinical Trial Site Elkhart Indiana 46514
Clinical Trial Site Evansville Indiana 47714
Clinical Trial Site Richmond Indiana 47374
Clinical Trial Site El Dorado Kansas 67042
Clinical Trial Site Newton Kansas 67114
Clinical Trial Site Wichita Kansas 67207
Clinical Trial Site Owensboro Kentucky 42303
Clinical Trial Site Monroe Louisiana 71201
Clinical Trial Site New Orleans Louisiana 70119
Clinical Trial Site Boston Massachusetts 02114
Clinical Trial Site West Springfield Massachusetts 01089
Clinical Trial Site Flint Michigan 48504
Clinical Trial Site Shelby Michigan 48315
Clinical Trial Site Ypsilanti Michigan 48197
Clinical Trial Site Minneapolis Minnesota 55404
Clinical Trial Site Richfield Minnesota 55423
Clinical Trial Site Columbus Mississippi 39705
Clinical Trial Site Tupelo Mississippi 38801
Clinical Trial Site Creve Coeur Missouri 63141
Clinical Trial Site Kalispell Montana 59901
Clinical Trial Site Lincoln Nebraska 68510
Clinical Trial Site Omaha Nebraska 68114
Clinical Trial Site Las Vegas Nevada 89121
Clinical Trial Site Portsmouth New Hampshire 03801
Clinical Trial Site Berlin New Jersey 08009
Clinical Trial Site Albuquerque New Mexico 87109
Clinical Trial Site New York New York 10017
Clinical Trial Site Charlotte North Carolina 28287
Clinical Trial Site Durham North Carolina 27704
Clinical Trial Site Durham North Carolina 27713
Clinical Trial Site Greensboro North Carolina 27401
Clinical Trial Site Greenville North Carolina 27834
Clinical Trial Site Monroe North Carolina 28112
Clinical Trial Site Raleigh North Carolina 27609
Clinical Trial Site Wilmington North Carolina 28403
Clinical Trial Site Winston-Salem North Carolina 27103
Clinical Trial Site Cleveland Ohio 44106
Clinical Trial Site Marion Ohio 43302
Clinical Trial Site Norman Oklahoma 73072
Clinical Trial Site Oklahoma City Oklahoma 73102
Clinical Trial Site Bethlehem Pennsylvania 18017
Clinical Trial Site Langhorne Pennsylvania 19047
Clinical Trial Site Newport Pennsylvania 17074
Clinical Trial Site Philadelphia Pennsylvania 19114
Clinical Trial Site East Providence Rhode Island 02914
Clinical Trial Site Myrtle Beach South Carolina 29572
Clinical Trial Site Rapid City South Dakota 57701
Clinical Trial Site Chattanooga Tennessee 37404
Clinical Trial Site Germantown Tennessee 38138
Clinical Trial Site Knoxville Tennessee 37909
Clinical Trial Site Knoxville Tennessee 37923
Clinical Trial Site Memphis Tennessee 38119
Clinical Trial Site Austin Texas 78744
Clinical Trial Site Coppell Texas 75019
Clinical Trial Site Dallas Texas 75230
Clinical Trial Site Dallas Texas 75234
Clinical Trial Site El Paso Texas 79925
Clinical Trial Site El Paso Texas 79935
Clinical Trial Site Houston Texas 77002
Clinical Trial Site Houston Texas 77024
Clinical Trial Site Houston Texas 77054
Clinical Trial Site Houston Texas 77081
Clinical Trial Site Houston Texas 77099
Clinical Trial Site Magnolia Texas 77355
Clinical Trial Site San Antonio Texas 78229
Clinical Trial Site San Antonio Texas 78240
Clinical Trial Site Shenandoah Texas 77384
Clinical Trial Site Sherman Texas 75092
Clinical Trial Site Stephenville Texas 76401
Clinical Trial Site Tomball Texas 77375
Clinical Trial Site Burlington Vermont 05401
Clinical Trial Site Burke Virginia 22015
Clinical Trial Site Manassas Virginia 20109
Clinical Trial Site Norfolk Virginia 23504
Clinical Trial Site West Allis Wisconsin 53227

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 56 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06272487, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 1, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06272487 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →